The Psychopharmacology Institute is an ongoing project with a core objective: to provide multimedia resources (video, illustrated articles) that help mental health professionals learn the essential aspects of psychopharmacology. Our concept of essential aspects includes: clinical and diagnostic background, pharmacological basis, effectiveness and adverse effects of psychotropic medications.
Clinical psychopharmacology plays an important role in the treatment of people suffering from mental disorders. It is important to note that in order to help patients achieve recovery, biological therapies often need to be combined with other therapeutic resources such as psychotherapy or other psychosocial interventions.
Depending on where you are geographically located, some pages may display advertising. These banners are served by one of our partners, UBM Medica. The display of these ads does not influence the content in any form.
Conflicts of interest
The editor declares that he has not received funding or educational grants for the development of any of the educational materials on this site. The costs of content creation, hosting, development and other expenses are covered entirely by the editor, Dr. Flavio Guzman.
About the editor: Flavio Guzman, MD
Dr. Guzman is a psychiatrist serving as Adjunct Professor at the Department of Pharmacology and Neurosciences, University of Mendoza.
Dr. Guzman started this site to share his interest in psychopharmacology education with a worldwide audience. His intention is to provide professionals in the mental health field with unbiased and clinically relevant training.
Feedback from readers
Readers have found our approach very useful, some of them have taken the time to send us e-mails:
“Your videos are a very nice and straight to the point summary of important points. I will be recommending them to medical students and residents.”
Patricia Maria de Carvalho Aguiar, MD. PhD.